CVRx, Inc. announced new real-world evidence demonstrating that use of the company’s Barostim implant was associated wit ...

Penumbra recently announced the launch of the Lightning Bolt 12 and the Lightning Bolt 6X with Trax systems, the next ...

Penumbra announced that it has launched the Element vascular access system, a laser-cut hypotube sheath designed for treating ...

AngioDynamics, Inc. announced the commencement of the AMBITION BTK multicenter randomized controlled trial (RCT), which will ...

Management of ALI includes anticoagulation, open thrombectomy, surgical bypass, catheter-directed thrombolysis (CDT), endovascular thrombectomy, and a combination of open and endovascular techniques.

CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...

Guerbet announced that its Lipiojoint transient liquid embolic agent received Breakthrough Device status from the United State ...

In a multicenter, retrospective review of patients admitted with intact and ruptured abdominal aortic aneurysms (AAAs), ...

Chronic limb-threatening ischemia (CLTI) is a challenging disease to treat, requiring a tailored approach and comprehensive endovascular toolbox. The goal of treatment is to achieve wound healing, ...

Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Arsenal Medical announced the completion of the initial cohort enrollment in the EMBO-02 clinical study of the company’s ...